BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 28648948)

  • 21. Prophylactic cranial irradiation in patients with small cell lung cancer. A retrospective study of recurrence, survival and morbidity.
    Ramlov A; Tietze A; Khalil AA; Knap MM
    Lung Cancer; 2012 Sep; 77(3):561-6. PubMed ID: 22677428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?
    Farooqi AS; Holliday EB; Allen PK; Wei X; Cox JD; Komaki R
    Radiother Oncol; 2017 Feb; 122(2):307-312. PubMed ID: 28073578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.
    Wolfson AH; Bae K; Komaki R; Meyers C; Movsas B; Le Pechoux C; Werner-Wasik M; Videtic GM; Garces YI; Choy H
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):77-84. PubMed ID: 20800380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Present role of prophylactic cranial irradiation].
    Le Péchoux C; Al Mohkles H; Dhermain F
    Bull Cancer; 2013 Jan; 100(1):35-43. PubMed ID: 23306141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twice-daily prophylactic cranial irradiation for patients with limited disease small-cell lung cancer with complete response to chemotherapy and consolidative radiotherapy: report of a single institutional phase II trial.
    Wolfson AH; Bains Y; Lu J; Etuk B; Sridhar K; Raub W; Markoe A
    Am J Clin Oncol; 2001 Jun; 24(3):290-5. PubMed ID: 11404503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Response and Prophylactic Cranial Irradiation Are Prognostic Factors in a Real-life Limited-disease Small-cell Lung Cancer Patient Cohort Comprehensively Staged With Cranial Magnetic Resonance Imaging.
    Eze C; Roengvoraphoj O; Niyazi M; Hildebrandt G; Fietkau R; Belka C; Manapov F
    Clin Lung Cancer; 2017 Jul; 18(4):e243-e249. PubMed ID: 28065620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic cranial irradiation in small cell lung cancer: a single institution experience.
    Naidoo J; Kehoe M; Sasiadek W; Hacking D; Calvert P
    Ir J Med Sci; 2014 Mar; 183(1):129-32. PubMed ID: 23760883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
    Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P
    Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.
    Gore EM; Bae K; Wong SJ; Sun A; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H
    J Clin Oncol; 2011 Jan; 29(3):272-8. PubMed ID: 21135270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy.
    Stanic K; Vrankar M; But-Hadzic J
    Radiol Oncol; 2020 Jul; 54(3):353-363. PubMed ID: 32726294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.
    Li N; Zeng ZF; Wang SY; Ou W; Ye X; Li J; He XH; Zhang BB; Yang H; Sun HB; Fang Q; Wang BX
    Ann Oncol; 2015 Mar; 26(3):504-9. PubMed ID: 25515658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic cranial irradiation could improve overall survival in patients with extensive small cell lung cancer : A retrospective study.
    Chen Y; Li J; Hu Y; Zhang Y; Lin Z; Zhao Z; Jiao S
    Strahlenther Onkol; 2016 Dec; 192(12):905-912. PubMed ID: 27605237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer.
    Patel S; Macdonald OK; Suntharalingam M
    Cancer; 2009 Feb; 115(4):842-50. PubMed ID: 19117355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial).
    Arrieta O; Maldonado F; Turcott JG; Zatarain-Barrón ZL; Barrón F; Blake-Cerda M; Cabrera-Miranda LA; Cardona AF; de la Garza JG; Rosell R
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1442-1450. PubMed ID: 33640422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment.
    Manapov F; Klöcking S; Niyazi M; Belka C; Hildebrandt G; Fietkau R; Klautke G
    Strahlenther Onkol; 2012 Jan; 188(1):29-34. PubMed ID: 22189436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy.
    Roengvoraphoj O; Eze C; Niyazi M; Li M; Hildebrandt G; Fietkau R; Belka C; Manapov F
    Strahlenther Onkol; 2017 Feb; 193(2):150-155. PubMed ID: 27853828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation.
    Bernhardt D; Bozorgmehr F; Adeberg S; Opfermann N; von Eiff D; Rieber J; Kappes J; Foerster R; König L; Thomas M; Debus J; Steins M; Rieken S
    Lung Cancer; 2016 Nov; 101():76-81. PubMed ID: 27794411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer.
    Ge XH; Lin Q; Ren XC; Liu YE; Chen XJ; Wang DY; Wang YQ; Cao B; Li ZG; Liu ML
    Radiat Oncol; 2013 Oct; 8():238. PubMed ID: 24125485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial.
    Levy A; Le Péchoux C; Mistry H; Martel-Lafay I; Bezjak A; Lerouge D; Padovani L; Taylor P; Faivre-Finn C
    J Thorac Oncol; 2019 Feb; 14(2):294-297. PubMed ID: 30292850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis.
    Schild SE; Foster NR; Meyers JP; Ross HJ; Stella PJ; Garces YI; Olivier KR; Molina JR; Past LR; Adjei AA;
    Ann Oncol; 2012 Nov; 23(11):2919-2924. PubMed ID: 22782333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.